Multitarget molecular hybrids of cinnamic acids

Area of Science:

• Medicinal Chemistry
• Drug Discovery
• Organic Synthesis

Background:

• Multitarget agents offer therapeutic advantages by addressing multiple disease pathways simultaneously.
• Developing novel compounds with combined anti-inflammatory and analgesic properties is a key area in pharmaceutical research.

Purpose of the Study:

• To synthesize and evaluate novel hybrid molecules incorporating cinnamic acid derivatives and phenolic moieties.
• To identify compounds with significant lipoxygenase (LOX) inhibitory, analgesic, and anti-proteolytic activities.

Main Methods:

• Synthesis of eleven novel hybrid compounds.
• In vitro evaluation of lipoxygenase (LOX) inhibition and anti-proteolytic activity.
• Assessment of analgesic activity and structure-activity relationships (SAR).
• Molecular docking studies to elucidate binding mechanisms.

Main Results:

• Three hybrids (2e, 2a, 2g) and 3b exhibited multifunctional activities.
• Hybrid 2e showed potent LOX inhibition (IC50 = 0.34 μM) and high analgesic activity (98.1%).
• Hybrid 3b displayed good LOX inhibition (IC50 = 50 μM) and potent anti-proteolytic activity (IC50 = 5 μM).
• Hybrid 2a demonstrated high analgesic activity (91%) and potential for peripheral nerve injury treatment.
• Ester derivatives, particularly those from paracetamol and m-acetamidophenol, were highly potent.

Conclusions:

• The synthesized hybrids represent promising candidates for multitarget therapeutic agents.
• Steric and electronic parameters significantly influence the compounds' activity.
• Allosteric interactions are suggested as the mechanism for LOX-inhibitor binding.